Prostate Cancer (Active) VA Disability Rating is rated by the U.S. Department of Veterans Affairs under DC 7528 of 38 C.F.R. § 4.115b across 3 severity tiers (60% -- Absorbent materials changed >4x/day or appliance required / 40% -- Absorbent materials changed 2-4x/day / 20% -- Absorbent materials changed <2x/day). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Prostate cancer (DC 7528) rates 100% during active malignancy and treatment. After treatment, rated on residual voiding dysfunction. Presumptive for Agent Orange exposure under 38 C.F.R. 3.309(e).
Prostate Cancer (Active) (DC 7528) is evaluated under 38 C.F.R. § 4.115b using the genitourinary rating framework. Because it is rated by analogy to the general schedule, the 3 levels below describe the body-system criteria the VA applies — the percentage assigned to Prostate Cancer (Active) depends on the specific findings (range of motion, frequency, severity, or functional loss) documented at the C&P exam and in the medical record.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.